EQS-Ad-hoc: Porsche Automobil Holding SE / Key word(s): Forecast Non-cash impairment risk of the at-equity carrying amounts of the investments in Volkswagen AG and Dr. Ing. h.c. F. Porsche AG is expected to lead to an accounting loss in the consolidated financial statements of Porsche Automobil Holding SE;
Withdrawal of the earnings forecast; Non-cash impairment risk of the investment in Dr. Ing. h.c. F. Porsche AG in the annual financial statements of Porsche Automobil Holding SE is expected to lead to an impairment loss Porsche Automobil Holding SE (Porsche SE) is obliged to carry out impairment tests in accordance with the applicable accounting standards. For the impairment tests of the carrying amounts of its investments in Volkswagen AG, Wolfsburg, and Dr. Ing. h.c. F. Porsche AG (Porsche AG), Stuttgart, Porsche SE has so far relied in particular on corporate planning data of these investments. Today, Volkswagen AG has informed Porsche SE that the current planning of Volkswagen AG and Porsche AG is no longer expected to be concluded by 31 December 2024. Consequently, as of now, Porsche SE cannot rely on the results of a current approved plan of Volkswagen AG and Porsche AG for accounting purposes. Against this background, the Management Board of Porsche SE will use for the impairment tests on the carrying amounts of the investments in Volkswagen AG and Porsche AG in particular external analyst expectations. On this basis, the Management Board of Porsche SE currently assumes that the impairment tests to be carried out as of 31 December 2024 on the carrying amounts of the investments in Volkswagen AG and Porsche AG in the consolidated balance sheet of Porsche SE as of 31 December 2024 are likely to result in impairment losses. As a result, the Management Board expects that the group result after tax of Porsche SE for the 2024 financial year will be significantly negative. In light of the expected impairment losses, Porsche SE is therefore withdrawing its current forecast for group result after tax in the range of 2.4 billion euros to 4.4 billion euros for the 2024 financial year. At this point in time, due to among other things the market environment with further increasing uncertainties, lower demand than originally expected on various markets and increasing geopolitical tensions and protectionist tendencies, the effects of the impairment tests as of 31 December 2024 on the carrying amounts of the investments to be recognized at Porsche SE can only be roughly estimated on the basis of preliminary valuation models. For the time being, Porsche SE assumes an impairment of the carrying amount of the investment in Volkswagen AG in the expected range from minus 7 billion euros to minus 20 billion euros and of the carrying amount of the investment in Porsche AG in the expected range from minus 1 billion euros to minus 2 billion euros in the consolidated balance sheet of Porsche SE. Therefore, Porsche SE expects that the values in use for the investments in Volkswagen AG and Porsche AG will continue to be significantly higher than their respective stock market values. A finalization of the impairment tests of Porsche SE can only take place after 31 December 2024, at the earliest when the market parameters and balance sheet data of the investments as of 31 December 2024 and the forecasts of the investments in Volkswagen AG and Porsche AG for the 2025 financial year are available, and thus not before the preparation of the annual and consolidated financial statements of Volkswagen AG and Porsche AG. The expected impairment loss in the consolidated financial statements of Porsche SE in relation to Volkswagen AG will probably not have an impact on the annual financial statements of Porsche SE under German commercial law. The Management Board of Porsche SE assumes that the expected impairment loss in the consolidated financial statements of Porsche SE in relation to Porsche AG will also have an impact on the annual financial statements of Porsche SE under German commercial law, however to a lower extent. Nevertheless, the Management Board of Porsche SE continues to assume that a dividend will be distributed for the 2024 financial year. The expected impairment losses at the level of Porsche SE or the Porsche SE Group will not have a cash effect and will not affect the forecasts communicated by Volkswagen AG and Porsche AG for the 2024 financial year. Porsche SE confirms its forecast for the net debt of the Porsche SE Group as of 31 December 2024, which is expected to be between 5.0 billion euros and 5.5 billion euros. Contact: Karsten Hoeldtke Head of Investor Relations +49-711-911-11023 karsten.hoeldtke@porsche-se.com End of Inside Information
13-Dec-2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
Language: | English |
Company: | Porsche Automobil Holding SE |
Porscheplatz 1 | |
70435 Stuttgart | |
Germany | |
Phone: | +49 (0)711 911-11023 |
Fax: | +49 (0)711 911-11819 |
E-mail: | InvestorRelations@porsche-se.com |
Internet: | www.porsche-se.com |
ISIN: | DE000PAH0038, XS2615940215 , XS2643320018, XS2643320109, XS2802891833, XS2802892054 |
WKN: | PAH003 |
Indices: | DAX |
Listed: | Regulated Market in Berlin, Frankfurt (General Standard), Munich, Stuttgart; Regulated Unofficial Market in Dusseldorf, Hamburg, Hanover, Tradegate Exchange; Luxembourg Stock Exchange |
EQS News ID: | 2051273 |
End of Announcement | EQS News Service |
|
2051273 13-Dec-2024 CET/CEST
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.